Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Troussard

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
BMC Research Notes|July 4, 2020
Analysis of medico-social factors for return to work among patients presenting with haematological malignancy (adamantine): results of a 'pilot study'Bénédicte Clin, Natacha Heutte, Mathilde Boulanger, et al.
Hematological Oncology|September 29, 2016
Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemiaYannick Le Bris, Stéphanie Struski, Romain Guièze, et al.
Medicine|December 1, 2016
Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia: A retrospective single-center studyMathieu Vautier, Hubert de Boysson, Christian Creveuil, et al.
The Analyst|May 29, 2015
Diagnosis approach of chronic lymphocytic leukemia on unstained blood smears using Raman microspectroscopy and supervised classificationTeddy Happillon, Valérie Untereiner, Abdelilah Beljebbar, et al.
International Journal of Cancer|October 5, 2012
Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in FranceAlain Monnereau, Xavier Troussard, Aurélien Belot, et al.
Blood Advances|May 18, 2022
A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemiaAlessandro Broccoli, Lisa Argnani, Matthew Cross, et al.
Frontiers in Oncology|August 1, 2022
Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled TrialsClaudia Vener, Silvia Rossi, Pamela Minicozzi, et al.
International Journal of Cancer|March 18, 2003
BCL-2/JH translocation in peripheral blood lymphocytes of unexposed individuals: lack of seasonal variations in frequency and molecular featuresSandrine Roulland, Pierre Lebailly, Gilbert Roussel, et al.
Annals of Hematology|July 5, 2014
Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemiaEdouard Cornet, Alain Delmer, Pierre Feugier, et al.
Journal of Occupational and Environmental Medicine|January 31, 2008
Occupation and lymphoid malignancies: results from a French case-control studyLaurent Orsi, Xavier Troussard, Alain Monnereau, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
BMC Research Notes|July 4, 2020
Analysis of medico-social factors for return to work among patients presenting with haematological malignancy (adamantine): results of a 'pilot study'Bénédicte Clin, Natacha Heutte, Mathilde Boulanger, et al.
Hematological Oncology|September 29, 2016
Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemiaYannick Le Bris, Stéphanie Struski, Romain Guièze, et al.
Medicine|December 1, 2016
Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia: A retrospective single-center studyMathieu Vautier, Hubert de Boysson, Christian Creveuil, et al.
The Analyst|May 29, 2015
Diagnosis approach of chronic lymphocytic leukemia on unstained blood smears using Raman microspectroscopy and supervised classificationTeddy Happillon, Valérie Untereiner, Abdelilah Beljebbar, et al.
International Journal of Cancer|October 5, 2012
Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in FranceAlain Monnereau, Xavier Troussard, Aurélien Belot, et al.
Blood Advances|May 18, 2022
A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemiaAlessandro Broccoli, Lisa Argnani, Matthew Cross, et al.
Frontiers in Oncology|August 1, 2022
Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled TrialsClaudia Vener, Silvia Rossi, Pamela Minicozzi, et al.
International Journal of Cancer|March 18, 2003
BCL-2/JH translocation in peripheral blood lymphocytes of unexposed individuals: lack of seasonal variations in frequency and molecular featuresSandrine Roulland, Pierre Lebailly, Gilbert Roussel, et al.
Annals of Hematology|July 5, 2014
Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemiaEdouard Cornet, Alain Delmer, Pierre Feugier, et al.
Journal of Occupational and Environmental Medicine|January 31, 2008
Occupation and lymphoid malignancies: results from a French case-control studyLaurent Orsi, Xavier Troussard, Alain Monnereau, et al.
Pageof 16